RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Piras, S ^a   Furfaro, A L ^b   Domenicotti, C ^a   Traverso, N ^a   Marinari, U M ^a   Pronzato, M A ^a   Nitti, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SIGNALING; CELLS; CYTOLOGY; PROTEINS;

ADVANCED GLYCATION END PRODUCTS; AMYLOID-BETA PEPTIDES; CELL SURVIVAL; NADPH OXIDASE; NEURONAL CELL; REACTIVE OXYGEN SPECIES; REDOX STATE; ROS GENERATIONS;

NEURONS;

ADVANCED GLYCATION END PRODUCT RECEPTOR; REACTIVE OXYGEN METABOLITE; ADVANCED GLYCATION END PRODUCT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

CELL SURVIVAL; HUMAN; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; CELL DIFFERENTIATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NADPH OXIDASE; NEURONS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84975104902     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/9348651     Document Type: Review

References (113)

1. D. Stern, S. D. Yan, S. F. Yan, and A. M. Schmidt, "Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings," Advanced Drug Delivery Reviews, vol. 54, no. 12, pp. 1615-1625, 2002.
2. A. Bierhaus, P. M. Humpert, M. Morcos et al., "Understanding RAGE, the receptor for advanced glycation end products," Journal of Molecular Medicine, vol. 83, no. 11, pp. 876-886, 2005.
3. R. Ramasamy, S. J. Vannucci, S. S. D. Yan, K. Herold, S. F. Yan, and A.M. Schmidt, "Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation," Glycobiology, vol. 15, no. 7, pp. 16R-28R, 2005.
4. J. Kim, C. K. Wan, S. J. O'Carroll, S. B. Shaikh, and L. F. B. Nicholson, "The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation," Journal of Neuroscience Research, vol. 90, no. 6, pp. 1136-1147, 2012.
5. M. Neeper, A. M. Schmidt, J. Brett et al., "Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins," The Journal of Biological Chemistry, vol. 267, no. 21, pp. 14998-15004, 1992.
6. A. M. Schmidt, "Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface," Journal of Biological Chemistry, vol. 267, no. 21, pp. 14987-14997, 1992.
7. A. M. Schmidt, R. Mora, R. Cao et al., "The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide," The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9882-9888, 1994.
8. K. Sugaya, T. Fukagawa, K.-I. Matsumoto et al., "Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3," Genomics, vol. 23, no. 2, pp. 408-419, 1994.
9. P. Malherbe, J.G. Richards, H. Gaillard et al., "cDNAcloning of a novel secreted isoformof the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein," Molecular Brain Research, vol. 71, no. 2, pp. 159-170, 1999.
10. H. Yonekura, Y. Yamamoto, S. Sakurai et al., "Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury," Biochemical Journal, vol. 370, no. 3, pp. 1097-1109, 2003.
11. C. Schlueter, S. Hauke, A. M. Flohr, P. Rogalla, and J. Bullerdiek, "Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing?" Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, vol. 1630, no. 1, pp. 1-6, 2003.
12. L. Zhang, M. Bukulin, E. Kojro et al., "Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases," Journal of Biological Chemistry, vol. 283, no. 51, pp. 35507-35516, 2008.
13. Y.K. Chuah, R. Basir, H. Talib, T.H. Tie, and N. Nordin, "Receptor for advanced glycation end products and its involvement in inflammatory diseases," International Journal of Inflammation, vol. 2013, Article ID403460, 15 pages, 2013.
14. O. Hori, J. Brett, T. Slattery et al., "The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system," The Journal of Biological Chemistry, vol. 270, no. 43, pp. 25752-25761, 1995.
15. J. Brett, A. M. Schmidt, S. D. Yan et al., "Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues,"American Journal of Pathology, vol. 143, no. 6, pp. 1699-1712, 1993.
16. C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, and A. Simm, "Role of advanced glycation end products in cellular signaling," Redox Biology, vol. 2, no. 1, pp. 411-429, 2014.
17. H. J. Huttunen, J. Kuja-Panula, G. Sorci, A. L. Agneletti, R. Donato, and H. Rauvala, "Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation," The Journal of Biological Chemistry, vol. 275, no. 51, pp. 40096-40105, 2000.
18. A. Schmidt, B. Kuhla, K. Bigl, G. Münch, and T. Arendt, "Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products," Journal of Neural Transmission, vol. 114, no. 11, pp. 1413-1424, 2007.
19. J. Qin, R. Goswami, S. Dawson, and G. Dawson, "Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress," Journal of Neuroscience Research, vol. 86, no. 11, pp. 2414-2422, 2008.
20. A. M. Schmidt, S. D. Yan, and D. M. Stern, "The dark side of glucose," Nature Medicine, vol. 1, no. 10, pp. 1002-1004, 1995.
21. H. Vlassara, R. Bucala, and L. Striker, "Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging," Laboratory Investigation, vol. 70, no. 2, pp. 138-151, 1994.
22. M. Brownlee, "Negative consequences of glycation," Metabolism: Clinical and Experimental, vol. 49, no. 2, supplement 1, pp. 9-13, 2000.
23. M.-X. Fu, K. J. Wells-Knecht, J. A. Blackledge, T. J. Lyons, S. R. Thorpe, and J. W. Baynes, "Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction," Diabetes, vol. 43, no. 5, pp. 676-683, 1994.
24. F. Giacco and M. Brownlee, "Oxidative stress and diabetic complications," Circulation Research, vol. 107, no. 9, pp. 1058-1070, 2010.
25. A. Moh, N. Sakata, S. Takebayashi et al., "Increased production of urea hydrogen peroxide from Maillard reaction and a UHPFenton pathway related to glycoxidation damage in chronic renal failure," Journal of the American Society of Nephrology, vol. 15, no. 4, pp. 1077-1085, 2004.
26. G. Münch, W. Deuther-Conrad, and J. Gasic-Milenkovic, "Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease-a target for neuroprotective treatment strategies?" Journal of Neural Transmission, Supplement, no. 62, pp. 303-307, 2002.
27. J. R. Kizer, D. Benkeser, A. M. Arnold et al., "Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults," Atherosclerosis, vol. 235, no. 1, pp. 116-121, 2014.
28. E. Schleicher and U. Friess, "Oxidative stress, AGE, and atherosclerosis," Kidney International. Supplement, no. 106, pp. S17-S26, 2007.
29. L. G. Bucciarelli, T. Wendt, L. Rong et al., "RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease," Cellular and Molecular Life Sciences, vol. 59, no. 7, pp. 1117-1128, 2002.
30. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, "The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses," Journal of Clinical Investigation, vol. 108, no. 7, pp. 949-955, 2001.
31. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, "The biology of the receptor for advanced glycation end products and its ligands," Biochimica et Biophysica Acta, vol. 1498, no. 2-3, pp. 99-111, 2000.
32. H. Wang, O. Bloom, M. Zhang et al., "HMG-1 as a latemediator of endotoxin lethality in mice," Science, vol. 285, no. 5425, pp. 248-251, 1999.
33. U. Andersson and K. J. Tracey, "HMGB1 in sepsis," Scandinavian Journal of Infectious Diseases, vol. 35, no. 9, pp. 577-584, 2003.
34. C. J. Treutiger, G. E. Mullins, A.-S. M. Johansson et al., "High mobility group 1 B-box mediates activation of human endothelium," Journal of Internal Medicine, vol. 254, no. 4, pp. 375-385, 2003.
35. H. J. Huttunen, C. Fages, and H. Rauvala, "Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways," Journal of Biological Chemistry, vol. 274, no. 28, pp. 19919-19924, 1999.
36. D. K. H. Chou, J. Zhang, F. I. Smith, P. McCaffery, and F. B. Jungalwala, "Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration," Journal of Neurochemistry, vol. 90, no. 6, pp. 1389-1401, 2004.
37. M. A. Hofmann, S. Drury, C. Fu et al., "RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides," Cell, vol. 97, no. 7, pp. 889-901, 1999.
38. I. Marenholz, C. W. Heizmann, and G. Fritz, "S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature)," Biochemical and Biophysical Research Communications, vol. 322, no. 4, pp. 1111-1122, 2004.
39. D. J. Selkoe, "Alzheimer's disease. In the beginning," Nature, vol. 354, no. 6353, pp. 432-433, 1991.
40. M. R. Chapman, L. S. Robinson, J. S. Pinkner et al., "Role of Escherichia coli curli operons in directing amyloid fiber formation," Science, vol. 295, no. 5556, pp. 851-855, 2002.
41. N. Sasaki, M. Takeuchi, H. Chowei et al., "Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques," Neuroscience Letters, vol. 326, no. 2, pp. 117-120, 2002.
42. T. Chavakis, A. Bierhaus, N. Al-Fakhri et al., "The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment," Journal of Experimental Medicine, vol. 198, no. 10, pp. 1507-1515, 2003.
43. J. Xie, J. D. Méndez, V. Méndez-Valenzuela, and M. M. Aguilar-Hernández, "Cellular signalling of the receptor for advanced glycation end products (RAGE)," Cellular Signalling, vol. 25, no. 11, pp. 2185-2197, 2013.
44. G. Sorci, F. Riuzzi, I. Giambanco, and R. Donato, "RAGE in tissue homeostasis, repair and regeneration," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1833, no. 1, pp. 101-109, 2013.
45. M. Nitti, C. D'Abramo, N. Traverso et al., "Central role of PKCδ in glycoxidation-dependent apoptosis of human neurons," Free Radical Biology and Medicine, vol. 38, no. 7, pp. 846-856, 2005.
46. Y. Xu, S. Wang, L. Feng, Q. Zhu, P. Xiang, and B. He, "Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation," International Immunopharmacology, vol. 10, no. 12, pp. 1552-1559, 2010.
47. C. A. Downs, L. H. Kreiner, N. M. Johnson, L. A. Brown, and M. N. Helms, "Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91phox signaling to epithelial sodium channels," American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 1, pp. 75-87, 2015.
48. S. D. Yan, A. M. Schmidt, G. M. Anderson et al., "Enhanced cellular oxidant stress by the interaction of advanced glycation end productswith their receptors/binding proteins,"The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9889-9897, 1994.
49. M. Brownlee, "Biochemistry and molecular cell biology of diabetic complications," Nature, vol. 414, no. 6865, pp. 813-820, 2001.
50. S.-I. Yamagishi, S. Maeda, T. Matsui, S. Ueda, K. Fukami, and S. Okuda, "Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes," Biochimica et Biophysica Acta, vol. 1820, no. 5, pp. 663-671, 2012.
51. C. Koulis, A. M. D. Watson, S. P. Gray, and K. A. Jandeleit-Dahm, "Linking RAGE and Nox in diabetic micro- and macrovascular complications,"Diabetes and Metabolism, vol. 41, no. 4, pp. 272-281, 2015.
52. A. R. Cross and A. W. Segal, "The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems," Biochimica et Biophysica Acta (BBA)- Bioenergetics, vol. 1657, no. 1, pp. 1-22, 2004.
53. K. Bedard and K.-H. Krause, "The NOX family of ROSgenerating NADPHoxidases: physiology and pathophysiology," Physiological Reviews, vol. 87, no. 1, pp. 245-313, 2007.
54. G.M. Bokoch and U. G. Knaus, "NADPH oxidases: not just for leukocytes anymore!," Trends in Biochemical Sciences, vol. 28, no. 9, pp. 502-508, 2003.
55. S. Sorce and K.-H. Krause, "NOX enzymes in the central nervous system: from signaling to disease," Antioxidants and Redox Signaling, vol. 11, no. 10, pp. 2481-2504, 2009.
56. Z. Nayernia, V. Jaquet, and K.-H. Krause, "Newinsights on NOX enzymes in the central nervous system," Antioxidants & Redox Signaling, vol. 20, no. 17, pp. 2815-2837, 2014.
57. A. Wong, S. Dukic-Stefanovic, J. Gasic-Milenkovic et al., "Antiinflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia," European Journal of Neuroscience, vol. 14, no. 12, pp. 1961-1967, 2001.
58. A. San Martin, R. Foncea, F. R. Laurindo, R. Ebensperger, K. K. Griendling, and F. Leighton, "Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products," Free Radical Biology and Medicine, vol. 42, no. 11, pp. 1671-1679, 2007.
59. H. M. Lander, J. M. Tauras, J. S. Ogiste, O. Hori, R. A. Moss, and A. M. Schmidt, "Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogenactivated protein kinase pathway regulated by oxidant stress," The Journal of Biological Chemistry, vol. 272, no. 28, pp. 17810-17814, 1997.
60. G. Basta, G. Lazzerini, S. Del Turco, G. M. Ratto, A. M. Schmidt, and R. De Caterina, "At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesionmolecule-1 induction by advanced glycation end products," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1401-1407, 2005.
61. L. L. Rong, S.-F. Yan, T. Wendt et al., "RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowthpathways,"The FASEB Journal, vol. 18, no. 15, pp. 1818-1825, 2004.
62. L. L. Rong, W. Trojaborg, W. Qu et al., "Antagonism of RAGE suppresses peripheral nerve regeneration," The FASEB Journal, vol. 18, no. 15, pp. 1812-1817, 2004.
63. V. Meneghini, M. T. Francese, L. Carraro, and M. Grilli, "Anovel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone," Molecular and Cellular Neuroscience, vol. 45, no. 2, pp. 139-150, 2010.
64. V. Meneghini, V. Bortolotto, M. T. Francese et al., "Highmobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB Axis: relevance for Alzheimer's disease," Journal of Neuroscience, vol. 33, no. 14, pp. 6047-6059, 2013.
65. M. Li, L. Sun, Y. Luo, C. Xie, Y. Pang, and Y. Li, "High-mobility group box 1 released from astrocytes promotes the proliferation of cultured neural stem/progenitor cells," International Journal of Molecular Medicine, vol. 34, no. 3, pp. 705-714, 2014.
66. R. Donato, G. Sorci, F. Riuzzi et al., "S100B's double life: intracellular regulator and extracellular signal," Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 1008-1022, 2009.
67. A. Saleh, D. R. Smith, L. Tessler et al., "Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons," Experimental Neurology, vol. 249, pp. 149-159, 2013.
68. L. Wang, S. Li, and F. B. Jungalwala, "Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth," Journal of Neuroscience Research, vol. 86, no. 6, pp. 1254-1266, 2008.
69. G. Sajithlal, H. Huttunen, H. Rauvala, and G. Münch, "Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells," The Journal of Biological Chemistry, vol. 277, no. 9, pp. 6888-6897, 2002.
70. S. Piras, A. L. Furfaro, A. Piccini et al., "Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation," Neurobiology of Aging, vol. 35, no. 6, pp. 1301-1308, 2014.
71. Y. Chen, S. Aulia, L. Li, and B. L. Tang, "AMIGOand friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs," Brain Research Reviews, vol. 51, no. 2, pp. 265-274, 2006.
72. Y. Chen, H. H. Hor, and B. L. Tang, "AMIGO is expressed in multiple brain cell types andmay regulate dendritic growth and neuronal survival," Journal of Cellular Physiology, vol. 227, no. 5, pp. 2217-2229, 2012.
73. T. Kajander, J. Kuja-Panula, H. Rauvala, and A. Goldman, "Crystal structure and role of glycans and dimerization in folding of neuronal leucine-rich repeat protein AMIGO-1," Journal of Molecular Biology, vol. 413, no. 5, pp. 1001-1015, 2011.
74. J. Kuja-Panula, M. Kiiltomäki, T. Yamashiro, A. Rouhiainen, and H. Rauvala, "AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats,"The Journal of Cell Biology, vol. 160, no. 6, pp. 963-973, 2003.
75. A. Piccini, R. Borghi, M. Guglielmotto et al., "β-Amyloid 1-42 induces physiological transcriptional regulation of BACE1," Journal of Neurochemistry, vol. 122, no. 5, pp. 1023-1031, 2012.
76. A. Kleindienst, M. J. McGinn, H. B. Harvey, R. J. Colello, R. J. Hamm, and M. R. Bullock, "Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury," Journal of Neurotrauma, vol. 22, no. 6, pp. 645-655, 2005.
77. H. J. Huttunen, J. Kuja-Panula, and H. Rauvala, "Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation," Journal of Biological Chemistry, vol. 277, no. 41, pp. 38635-38646, 2002.
78. S. Ortega-Martínez, "A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis," Frontiers in Molecular Neuroscience, vol. 8, article 46, 2015.
79. M. A. de Bittencourt Pasquali, V. M. De Ramos, R. D. Albanus et al., "Gene expression profile of NF-κB, Nrf2, glycolytic, and p53 pathways during the SH-SY5Y neuronal differentiation mediated by retinoic acid," Molecular Neurobiology, vol. 53, no. 1, pp. 423-435, 2016.
80. F. Zhao, T. Wu, A. Lau et al., "Nrf2 promotes neuronal cell differentiation," Free Radical Biology and Medicine, vol. 47, no. 6, pp. 867-879, 2009.
81. M. L. C. da Frota, A. S. Pires, F. Zeidán-Chuliá et al., "In vitro optimization of retinoic acid-induced neuritogenesis and TH endogenous expression in human SH-SY5Y neuroblastoma cells by the antioxidant Trolox," Molecular and Cellular Biochemistry, vol. 358, no. 1-2, pp. 325-334, 2011.
82. Z. Xun, D.-Y. Lee, J. Lim et al., "Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells," Mechanisms of Ageing and Development, vol. 133, no. 4, pp. 176-185, 2012.
83. L. Schneider, S. Giordano, B. R. Zelickson et al., "Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress," Free Radical Biology and Medicine, vol. 51, no. 11, pp. 2007-2017, 2011.
84. K. Suzukawa, K. Miura, J. Mitsushita et al., "Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species," The Journal of Biological Chemistry, vol. 275, no. 18, pp. 13175-13178, 2000.
85. V. Munnamalai and D. M. Suter, "Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth," Journal of Neurochemistry, vol. 108, no. 3, pp. 644-661, 2009.
86. R. Ray, J. K. Juranek, and V. Rai, "RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis," Neuroscience & Biobehavioral Reviews, vol. 62, pp. 48-55, 2016.
87. A. M. Vincent, L. Perrone, K. A. Sullivan et al., "Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress," Endocrinology, vol. 148, no. 2, pp. 548-558, 2007.
88. N. Origlia, M. Righi, S. Capsoni et al., "Receptor for advanced glycation end product-dependent activation of p38 mitogenactivated protein kinase contributes to amyloid-β-mediated cortical synaptic dysfunction," The Journal of Neuroscience, vol. 28, no. 13, pp. 3521-3530, 2008.
89. P. Teismann, K. Sathe, A. Bierhaus et al., "Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity," Neurobiology of Aging, vol. 33, no. 10, pp. 2478-2490, 2012.
90. L. Ma and L. F. B. Nicholson, "Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus," Brain Research, vol. 1018, no. 1, pp. 10-17, 2004.
91. J. K. Juranek, G. K. Daffu, J. Wojtkiewicz, D. Lacomis, J. Kofler, and A. M. Schmidt, "Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis," Frontiers in Cellular Neuroscience, vol. 9, article 485, 2015.
92. A. Hidmark, T. Fleming, S. Vittas et al., "A new paradigm to understand and treat diabetic neuropathy," Experimental and Clinical Endocrinology and Diabetes, vol. 122, no. 4, pp. 201-207, 2014.
93. M. Takeuchi and S.-I. Yamagishi, "Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease," Current Pharmaceutical Design, vol. 14, no. 10, pp. 973-978, 2008.
94. H. Zhang, Y. Wang, S. Yan et al., "Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury," Cell Death and Disease, vol. 5, no. 6, Article ID e1288, 2014.
95. R. Deane, I. Singh, A. P. Sagare et al., "A multimodal RAGEspecific inhibitor reduces amyloid γ-mediated brain disorder in a mouse model of Alzheimer disease," The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1377-1392, 2012.
96. Fang, L.-F. Lue, S. Yan et al., "RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease,"The FASEB Journal, vol. 24, no. 4, pp. 1043-1055, 2010.
97. R. Bianchi, I. Giambanco, and R. Donato, "S100B/RAGEdependent activation of microglia via NF-κB and AP-1. Coregulation of COX-2 expression by S100B, IL-1β and TNF-α," Neurobiology of Aging, vol. 31, no. 4, pp. 665-677, 2010.
98. S. Dukic-Stefanovic, J. Gasic-Milenkovic, W. Deuther-Conrad, and G. Münch, "Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs)," Journal of Neurochemistry, vol. 87, no. 1, pp.44-55, 2003.
99. R. Deane, S. D. Yan, R. K. Submamaryan et al., "RAGEmediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain," Nature Medicine, vol. 9, no. 7, pp. 907-913, 2003.
100. J. B. Mackic, M. Stins, J. G. McComb et al., "Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer," The Journal of Clinical Investigation, vol. 102, no. 4, pp. 734-743, 1998.
101. K. Takuma, F. Fang, W. Zhang et al., "RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20021-20026, 2009.
102. S.-W. Kim, C.-M. Lim, J.-B. Kim et al., "Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway," Neurotoxicity Research, vol. 20, no. 2, pp. 159-169, 2011.
103. S. Chen, L. Yin, Z. Xu et al., "Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis," Neuroscience Letters, vol. 612, pp. 193-198, 2016.
104. A. Saha, S.-J. Kim, Z. Zhang et al., "RAGE signaling contributes to neuroinflammation in infantile neuronal ceroid lipofuscinosis," FEBS Letters, vol. 582, no. 27, pp. 3823-3831, 2008.
105. Z. Zhang, Y.-C. Lee, S.-J. Kim et al., "Palmitoyl-protein thioesterase-1 deficiencymediates the activation of the unfolded protein response and neuronal apoptosis in INCL," Human Molecular Genetics, vol. 15, no. 2, pp. 337-346, 2006.
106. W. Paschen, "Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states," Cell Calcium, vol. 29, no. 1, pp. 1-11, 2001.
107. S.M. Son, E. S. Jung, H. J. Shin, J. Byun, and I. Mook-Jung, "Aβ-induced formation of autophagosomes is mediated by RAGECaMKK β-AMPK signaling," Neurobiology of Aging, vol. 33, no. 5, pp. 1006.11-1006.23, 2012.
108. B. Kaltschmidt, M. Uherek, H. Wellmann, B. Volk, and C. Kaltschmidt, "Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9409-9414, 1999.
109. B. Kaltschmidt, T. Sparna, and C. Kaltschmidt, "Activation of NF-κB by reactive oxygen intermediates in the nervous system," Antioxidants & Redox Signaling, vol. 1, no. 2, pp. 129-144, 1999.
110. M. Nitti, A. L. Furfaro, N. Traverso et al., "PKC delta and NADPH oxidase in AGE-induced neuronal death," Neuroscience Letters, vol. 416, no. 3, pp. 261-265, 2007.
111. V. Kärkkäinen, Y. Pomeshchik, E. Savchenko et al., "Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity," STEM CELLS, vol. 32, no. 7, pp. 1904-1916, 2014.
112. H. Zhang, K. J. A. Davies, and H. J. Forman, "Oxidative stress response and Nrf2 signaling in aging," Free Radical Biology and Medicine, vol. 88, part B, pp. 314-316, 2015.
113. Y. Hong and Z. An, "Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-κB signaling," Archives of Pharmacal Research, 2015.